梅州做流产的医院梅州做人流去哪里好,梅州患了慢性淋菌性尿道炎该怎么办,梅州患了霉菌性尿道炎怎么办,梅州开外眼角术,梅州怎么医疗真菌阴道炎,梅州妇科qq咨询,梅州人工打胎价钱多少

BEIJING, March 8 (Xinhuanet) -- U.S. Food and Drug Administration (FDA) announced there was no new reason for safety concern in Pfizer Inc's Prevenar and Sanofi Aventis SA's ActHIBor vaccines, according to media reports Tuesday.Health agencies "have not detected new safety concerns or unusual reporting patterns" in the vaccines, which are used to prevent forms of meningitis and pneumonia, FDA spokeswoman Shelly Burgess said in an emailed statement.Health agencies in the United States will continue to monitor the vaccines for safety, the spokeswoman added.The Japanese health ministry had decided to suspend the vaccines after four unexplained deaths were reported. The causes of the deaths are still investigated, the Japanese ministry said in a release on its website.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

BEIJING, April 19 (Xinhuanet) -- The case in the Hollywood blockbuster "The Social Network" continues in real life.Twins Cameron and Tyler Winklevoss on Monday filed another appeal against their Harvard classmate and Facebook founder Mark Zuckerberg.The Winklevosses claim that the case needs to be reviewed by a special 11-judge panel in the latest appeal, after a three-judge panel of the 9th U.S. Circuit Court of Appeals ruled against the brothers last week.The twins initially claimed that Zuckerberg had stolen their idea for the website but agreed to drop their lawsuit in 2008 in exchange for 20 million dollars in cash and stock in the company.But later they discovered the stock was worth less than claimed at the time and sought to have the deal voided, the brothers said.

LOS ANGELES, March 2 (Xinhua) -- Those who take a nap are more likely to have lower levels of blood pressure despite stress, said a new study in the latest issue of International Journal of Behavioral Medicine available on Wednesday.In the study, researchers at Sarah Conklin of Allegheny College in Meadville, Pennsylvania examined 85 healthy university students, who were divided into two groups, with one group taking an hour- long nap during the day, and the other group having no time to sleep. Both groups were given a mental stress test.The study found that participants in both groups experienced increase in blood pressure and pulse rates when they took the stress test, but the average blood pressure of those who slept for at least 45 minutes was significantly lower after the stress test than it was for those who did not sleep.The researchers drew the conclusion that a daytime nap of at least 45 minutes may help stressed-out people lower their blood pressure and protect their heart."Our findings suggest that daytime sleep may offer cardiovascular benefit by accelerating cardiovascular recovery following mental stressors," the researchers said in the study."Further research is needed to explore the mechanism by which daytime sleep is linked with cardiovascular health and to evaluate daytime sleep as a recuperative and protective practice, especially for individuals with known cardiovascular disease risk and those with suboptimal sleep quality," they added.Sleep deficiency is common in the United States, posing a long- term health threat. On average, Americans get nearly two hours less sleep a night than they did 50 years ago, according to background information provided by the journal.

BEIJING, May 4 (Xinhuanet) -- No formalin has been found in the milk powder imported from S. Korea into China due to different milk sources, the general agency of South Korea's Maeil Dairies said Tuesday.The declaration came after Maeil Dairies, South Korea's third-largest dairy company, was found to have produced milk from cows given feed tainted with formalin.The agency said that the milk used in the dairy products exported to China comes from New Zealand, Europe and other places outside South Korea, so Chinese consumers should have nothing to worry about.Formalin, a liquid form of formaldehyde gas, was largely used in the past as a disinfectant, pesticide and bactericide for preservation of biological specimens.Its use has dwindled over the years due to health concerns.After the incident, South Korea has decided to conduct emergency inspections on milk sold in the market by four major dairy companies, to check the presence of formalin.